KALA BIO Inc. (NASDAQ:KALA)
Old Forum Content for KALAMake a Forum Post Become a member to view recent forum posts. Already a member? Sign in here.
- rjw225: @bigbartabs $KALA Thank you.
- rjw225: $KALA a question to the more advanced members -- is it a tradeable squeeze? Thanks.
- bigbartabs: @rjw225 $KALA ... I would say it is. If it hits 15.06, probably going higher. Next resistance point is probably around 15.43
- rjw225: $KALA question to the more experienced members: Looks like a short squeeze, doesn't it?
- scottrades: @rjw225 $KALA Certainly does! Not sure about the fundamental story but a monster move.
- woodman: @scottrades $KALA - So many end of year monster moves in #biotech. Even though the bio ETFs aren't doing much, a number of individual bio stocks have crushed it. It's been the best part of my portfolio here at the end of the year.
- scottrades: @woodman $KALA #biotech I agree. $XBI Still looks good on the Daily.
- rjw225: $KALA is on the move. It is a tiny investigational eye treatment company. I am in it long term and still under water but others may benefit from short swings.
- rjw225: $KALA is anybody in this stock? Is this an anti-short seller raid? Pray tell....
- jr3345: $KALA - Mfg medicines for dry eye. Recent FDA approval & received upgrade with price target of $21. long stock
- sierramp: @bRobert Do you know anything professionally about $KALA? They finished two phase III trials, got FDA approval in August for INVELTYS for temp relief of signs/symptoms of dry eye disease. They just did a secondary, looks like RA Capital Mgme got 4.5M shares. But the chart is pretty ugly.
- bRobert: @sierramp $KALA No insight. Ugly stick sell off. Someone wasn't happy.
- Aragorn: Recent IPOS making nice moves - $SNNA $KALA $AKSA - these are obviously risky -and thin do your own DD
- Vehid: ATH #IPO $VERI (two-folded in two weeks w/o me :( ) $AKCA $PLNT $URGN $SNNS $KALA $TRTX
- Bridget: @Vehid $VERI $AKCA $PLNT $URGN $SNNS $KALA $TRTX #IPO Also $SOI and $SGH
Kala Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary nanoparticle-based Mucus Penetrating Particles technology, with focus on the treatment of eye diseases.Request Video of KALA
Already a member? Sign in here.
- $12.19 117.09%
- $10.93 71.25%
- $29.00 62.82%
- $11.07 -40.70%
- $5.50 -25.80%
- $8.03 -24.31%
Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:
- Nightly video Strategy Sessions with a game plan for tomorrow
- Got a stock you want Dan to look at? Just ask.
- Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
- Access to over 90,400 stock analysis videos
- Access an ever expanding library (90,400) of educational videos that will save you time and make you money
Join a team of friends and traders that have one thing in common; a burning desire to succeed.
Become a Member Today!
Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...
Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!